Page last updated: 2024-08-17

levodopa and Disruptive, Impulse Control, and Conduct Disorders

levodopa has been researched along with Disruptive, Impulse Control, and Conduct Disorders in 71 studies

Research

Studies (71)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	13 (18.31)	29.6817
2010's	47 (66.20)	24.3611
2020's	11 (15.49)	2.80

Authors

Authors	Studies
Bergmann, M; Brandauer, E; Djamshidian, A; Ellmerer, P; Heim, B; Högl, B; Seppi, K; Stefani, A	1
Berg, D; Leplow, B; Liepelt-Scarfone, I; Maetzler, W; Michaelis, K; Renftle, D; Solbrig, S; Thomas, M	1
Torres, V; Valldeoriola, F	1
Contreras Chicote, A; Grandas Perez, F; Mas Serrano, M; Velilla Alonso, G	1
Antoniuk, S; Grażyńska, A; Siuda, J; Toś, M	1
Anheim, M; Grillon, A; Lipsker, D; Moegle, C; Velter, C	1
Brahimi, E; Calabresi, P; Cappelletti, G; Eusebi, P; Filidei, M; Nigro, P; Paoletti, FP; Parnetti, L; Santangelo, V; Simoni, S; Tambasco, N	1
Baik, JS; Cho, JW; Choi, JH; Jeon, B; Kim, HT; Kim, JM; Kim, JW; Koh, SB; Kwon, OD; Lee, HW; Lee, JY; Ma, HI; Yoon, WT	1
Baig, F; Drew, DS; Hu, M; Husain, M; Kelly, M; Manohar, S; Muhammed, K; Okai, D; Saleh, Y; Sarangmat, N	1
Aubignat, M; Krystkowiak, P; Tir, M	1
Huovinen, A; Jaakkola, E; Joutsa, J; Kaasinen, V	1
Kobylecki, C; Silverdale, MA	1
Clemm von Hohenberg, C; Dreßing, H	1
De Jesus, S; Foote, KD; Gunduz, A; Hess, CW; Martinez-Ramirez, D; Okun, MS; Rossi, PJ	1
Abbruzzese, G; Antonini, A; Biundo, R; Calandra-Buonaura, G; Cortelli, P; Jori, MC; Lopiano, L; Marconi, R; Matinella, A; Morgante, F; Nicoletti, A; Tamburini, T; Tinazzi, M; Vorovenci, RJ; Weis, L; Zappia, M	1
Arnulf, I; Benchetrit, E; Beudin, P; Cicolin, A; Cormier-Dequaire, F; Corvol, JC; Durif, F; Fantini, ML; Figorilli, M; Lacomblez, L; Lopiano, L; Marques, A; Pereira, B; Puligheddu, M; Zibetti, M	1
Arbelo, JM; Catalan, MJ; Cubo, E; Martinez-Martin, P; Mir, P; Molina-Arjona, JA	1
Beudin, P; Debilly, B; Derost, P; Durif, F; Fantini, ML; Figorilli, M; Marques, A; Pereira, B; Vidal, T	1
Baik, JS; Cho, J; Jeon, B; Kim, HT; Kim, JM; Kim, JW; Koh, SB; Kwon, OD; Lee, HW; Lee, JY; Ma, HI; Yoon, WT	1
Martinez-Castrillo, JC	1
Anheim, M; Ansquer, S; Azulay, JP; Bekadar, S; Benatru, I; Brefel-Courbon, C; Brice, A; Castrioto, A; Charbonnier-Beaupel, F; Cormier-Dequaire, F; Corvol, JC; Defebvre, L; Durif, F; Grabli, D; Krack, P; Kreisler, A; Krystkowiak, P; Lacomblez, L; Lagha-Boukbiza, O; Lebbah, S; Lebrun-Vignes, B; Lesage, S; Lhommée, E; Llorca, PM; Maltête, D; Mangone, G; Marques-Raquel, A; Ory-Magne, F; Pelissolo, A; Rascol, O; Roze, E; Tezenas du Montcel, S; Tir, M; Tranchant, C; Vidailhet, M	1
Kobayashi, S; Matsuda, N; Ugawa, Y	1
Januário, C; Morgadinho, A; Reis Carneiro, D; Sousa, M	1
Joutsa, J; Majuri, J	1
Sheehan, J; Thorpe, M; Wilson, L	1
Duarte, MB; Glass, PG; Mueller, M; Negreiros, NN; Oliveira-Filho, J; Valença, GT; Ventura, LM	1
Appel-Cresswell, S; Barton, JJ; McKeown, MJ; Sharp, ME; Stoessl, AJ; Viswanathan, J	1
Fedorova, NV; Nikitina, AV	1
Atmaca, M	1
Okun, MS; Weintraub, D	1
Alkufri, F; Brown, RG; Burn, DJ; Hindle, JV; Hurt, CS; Landau, S; Samuel, M; Wilson, KC	1
Alonso-Canovas, A; Garcia-Ruiz, PJ; Herranz Barcenas, A; Mahillo Fernandez, I; Martinez Castrillo, JC; Mata, M; Olmedilla Gonzalez, N; Sanchez Alonso, P; Vela, L	1
Evans, AH; Griffiths, RI; Horne, M; Kettlewell, J; Kotschet, K; McGregor, S	1
Berganzo, K; Gómez-Esteban, JC; Lezcano, E; Somme, JH; Tijero, B; Zarranz, JJ	1
Averbeck, BB; Aviles-Olmos, I; Djamshidian, A; Foltynie, T; Lawrence, AD; Lees, AJ; Magdalinou, N; O'Sullivan, SS; Tomassini, A; Warner, TT	1
Claassen, DO; Harrison, MB; Kanoff, K; Neimat, JS; van den Wildenberg, WP; van Wouwe, NC; Wylie, SA	1
Beaulieu-Boire, I; Lang, AE	1
Bellosta Diago, E; Lopez Del Val, LJ; López Garcia, E; Santos Lasaosa, S; Viloria Alebesque, A	1
Banerjee, M; Kishore, A; Krishnamoorthy, S; Krishnan, S; Kumar, H; Rajan, R; Sarma, G; Sarma, S	1
Bezard, E; Fernagut, PO; Frank, MJ; Grace, AA; Napier, TC; Obeso, J; Rodriguez-Oroz, M; Sgambato-Faure, V; Voon, V	1
Weintraub, D	1
Comella, C; Elmer, L; Hauser, RA; Lyons, KE; Pahwa, R; Simuni, T; Weintraub, D	1
Avanzi, M; Baratti, M; Bonfà, F; Cabri, G; Cabrini, S; Uber, E	1
Chan, P; Ding, H; Fan, W; Ma, J	1
Baunez, C; Bezard, E; Fernagut, PO; Juncos, JL; Obeso, JA; Pavon, N; Rodriguez, M; Voon, V; Wickens, J	1
Demiray, DY; Erginöz, E; Kenangil, G; Ozekmekçi, S; Sohtaoğlu, M	1
Koester, J; Lang, AE; Potenza, MN; Siderowf, AD; Stacy, M; Voon, V; Weintraub, D; Whetteckey, J; Wunderlich, GR	1
Dewey, RB	1
Alegre, M; Artieda, J; Garcia-Garcia, D; Guridi, J; López-Azcárate, J; Obeso, JA; Rodriguez-Oroz, MC; Toledo, J; Valencia, M	1
Ambermoon, P; Carter, A; Dissanayaka, NN; Hall, WD; O'Sullivan, JD	1
Jeon, BS; Kim, HJ; Lee, JY	1
Lang, AE; Potenza, MN; Siderowf, AD; Sohr, M; Stacy, M; Voon, V; Weintraub, D; Whetteckey, J; Wunderlich, GR	1
Fernandez, HH; Hicks, CW; Itin, I; Pandya, MM	1
Cardoso, F; Grosset, DG; Lees, A	1
Auyeung, M; Cheung, CM; Lee, CN; Li, R; Tang, WK; Tsoi, TH; Yeung, E	1
Carrière, N; Defebvre, L; Destée, A; Dujardin, K; Kreisler, A	1
Schnitzler, A; Südmeyer, M; Wojtecki, L	1
Farnikova, K; Kanovsky, P; Obereigneru, R; Prasko, J	1
Ardouin, C; Aya Kombo, M; Benabid, AL; Bichon, A; Bosson, JL; Broussolle, E; Carnicella, S; Chabardès, S; Fraix, V; Kistner, A; Klinger, H; Krack, P; Lhommée, E; Mertens, P; Pollak, P; Polo, G; Quesada, JL; Schmitt, E; Seigneuret, E; Thobois, S; Xie, J	1
Joutsa, J; Kaasinen, V; Martikainen, K; Vahlberg, T	1
Daghem, M; Grosset, DG; Grosset, KA; Macphee, GJ; Newman, EJ; Nissen, T; Odin, P; Pal, G; Stewart, M	1
Foote, KD; Hassan, A; Iyer, S; McFarland, NR; Okun, MS; Rodriguez, RL; Sriram, A; Ward, HE	1
Barbe, MT; Eggers, C; Pauls, KA; Salimi Dafsari, H; Timmermann, L	1
Avanzi, M; Bonfà, F; Uber, E	1
Ahlskog, JE; Bower, JH; Dodd, ML; Geda, YE; Josephs, KA; Klos, KJ	1
Iyer, SS; Morgan, JC; Sethi, KD	1
Larner, AJ	1
Butzkueven, H; Evans, AH	1
de Freitas, GR; Fontenelle, LF; Garcia, RF; Mendlowicz, MV; Nazar, BP; Ordacgi, L; Rosso, AL	1
Bermejo, F; Fraile, A; Jiménez-Jiménez, FJ; Molina, JA; Ortí-Pareja, M; Sáinz-Artiga, MJ; Villanueva, C	1

Reviews

8 review(s) available for levodopa and Disruptive, Impulse Control, and Conduct Disorders

Article	Year
Drug-induced impulse control disorders: a review. Current clinical pharmacology, 2014, Volume: 9, Issue:1 Topics: Antiparkinson Agents; Disruptive, Impulse Control, and Conduct Disorders; Dopamine; Dopamine Agonists; Humans; Levodopa; Parkinson Disease	2014
Should impulse control disorders and dopamine dysregulation syndrome be indications for deep brain stimulation and intestinal levodopa? Movement disorders : official journal of the Movement Disorder Society, 2013, Volume: 28, Issue:14 Topics: Antiparkinson Agents; Deep Brain Stimulation; Disruptive, Impulse Control, and Conduct Disorders; Humans; Intestines; Levodopa; Parkinson Disease	2013
Impulse control disorders and levodopa-induced dyskinesias in Parkinson's disease: an update. The Lancet. Neurology, 2017, Volume: 16, Issue:3 Topics: Antiparkinson Agents; Disruptive, Impulse Control, and Conduct Disorders; Dyskinesia, Drug-Induced; Humans; Levodopa; Parkinson Disease	2017
Treatment of early Parkinson's disease. Part 2. European neurology, 2009, Volume: 61, Issue:4 Topics: Antiparkinson Agents; Autonomic Nervous System Diseases; Clinical Trials as Topic; Cognition Disorders; Depression; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Humans; Levodopa; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Olfaction Disorders; Pain; Parkinson Disease; Psychotic Disorders; Sleep Wake Disorders; Time Factors	2009
Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders. The Lancet. Neurology, 2009, Volume: 8, Issue:12 Topics: Antiparkinson Agents; Automatism; Compulsive Behavior; Disruptive, Impulse Control, and Conduct Disorders; Dopamine; Dopamine Agents; Dyskinesia, Drug-Induced; Gambling; Humans; Levodopa; Parkinson Disease; Psychoses, Substance-Induced; Sexual Behavior	2009
Impulse control disorders in patients with Parkinson's disease receiving dopamine replacement therapy: evidence and implications for the addictions field. Addiction (Abingdon, England), 2011, Volume: 106, Issue:2 Topics: Adult; Aged; Behavior, Addictive; Binge-Eating Disorder; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Epidemiologic Factors; Epidemiologic Methods; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Sexual Dysfunctions, Psychological; Substance-Related Disorders	2011
[Current treatment strategies for Parkinson's disease]. Fortschritte der Neurologie-Psychiatrie, 2011, Volume: 79, Issue:12 Topics: Aged; Animals; Anti-Dyskinesia Agents; Antiparkinson Agents; Apomorphine; Critical Care; Deep Brain Stimulation; Dementia; Depression; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Europe; Female; Humans; Infusion Pumps, Implantable; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Psychotic Disorders; Sleep Wake Disorders; Tremor	2011
[Parkinson's disease: current standards in diagnostics and therapy]. Fortschritte der Neurologie-Psychiatrie, 2012, Volume: 80, Issue:10 Topics: Antidepressive Agents; Antiparkinson Agents; Deep Brain Stimulation; Disruptive, Impulse Control, and Conduct Disorders; Drug Implants; Gait Disorders, Neurologic; Humans; Levodopa; Parkinson Disease; Psychoses, Substance-Induced; Tremor	2012

Trials

3 trial(s) available for levodopa and Disruptive, Impulse Control, and Conduct Disorders

Article	Year
Behavioural and trait changes in parkinsonian patients with impulse control disorder after switching from dopamine agonist to levodopa therapy: results of REIN-PD trial. Journal of neurology, neurosurgery, and psychiatry, 2019, Volume: 90, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Drug Combinations; Drug Substitution; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole	2019
Impulse control disorders in Parkinson disease: a multicenter case--control study. Annals of neurology, 2011, Volume: 69, Issue:6 Topics: Aged; Analysis of Variance; Antiparkinson Agents; Case-Control Studies; Cognition Disorders; Cross-Sectional Studies; Disability Evaluation; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Female; Humans; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Psychiatric Status Rating Scales	2011
Pathological gambling caused by drugs used to treat Parkinson disease. Archives of neurology, 2005, Volume: 62, Issue:9 Topics: Adult; Aged; Antiparkinson Agents; Disruptive, Impulse Control, and Conduct Disorders; Female; Gambling; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Review Literature as Topic	2005

Other Studies

60 other study(ies) available for levodopa and Disruptive, Impulse Control, and Conduct Disorders

Article	Year
Factors associated with augmentation in patients with restless legs syndrome. European journal of neurology, 2022, Volume: 29, Issue:4 Topics: Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agents; Humans; Levodopa; Restless Legs Syndrome; Surveys and Questionnaires	2022
Characteristics of behavioural addiction in Parkinson's disease patients with self-reported impulse control disorder and controls matched for levodopa equivalent dose: a matched case-control study. Journal of neural transmission (Vienna, Austria : 1996), 2023, Volume: 130, Issue:2 Topics: Behavior, Addictive; Case-Control Studies; Disruptive, Impulse Control, and Conduct Disorders; Humans; Levodopa; Male; Parkinson Disease; Quality of Life	2023
Predicting impulse control disorder in Parkinson's Disease: Is there a formula? European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2023, Volume: 72 Topics: Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Food, Formulated; Humans; Levodopa; Parkinson Disease	2023
New-onset impulse control disorders after treatment with levodopa-carbidopa intestinal gel in Parkinson's disease. Neurologia, 2023, Volume: 38, Issue:3 Topics: Antiparkinson Agents; Carbidopa; Disruptive, Impulse Control, and Conduct Disorders; Humans; Levodopa; Parkinson Disease	2023
Impulse Control Disorders in the Polish Population of Patients with Parkinson's Disease. Medicina (Kaunas, Lithuania), 2023, Aug-16, Volume: 59, Issue:8 Topics: Disruptive, Impulse Control, and Conduct Disorders; Humans; Levodopa; Parkinson Disease; Poland; Prospective Studies	2023
Impulse control disorder-linked hypersexuality complicated by disseminated gonococcal infection in a patient with Parkinson's disease. Revue neurologique, 2020, Volume: 176, Issue:4 Topics: Amantadine; Apomorphine; Compulsive Behavior; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Female; Gonorrhea; Humans; Levodopa; Middle Aged; Parkinson Disease; Sexual Dysfunctions, Psychological; Tetrahydronaphthalenes; Thiophenes	2020
Impulse Control Disorders and Levodopa-Induced Dyskinesias in Parkinson's Disease: Pulsatile versus Continuous Dopaminergic Stimulation. Journal of Parkinson's disease, 2020, Volume: 10, Issue:3 Topics: Aged; Aged, 80 and over; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agents; Dyskinesias; Female; Humans; Impulsive Behavior; Levodopa; Male; Middle Aged; Parkinson Disease; Prevalence; Severity of Illness Index; Surveys and Questionnaires	2020
Neuropsychiatric Traits Associated with Refractory Impulse Control Disorder in Parkinson's Disease. Neuro-degenerative diseases, 2019, Volume: 19, Issue:5-6 Topics: Anger; Antiparkinson Agents; Case-Control Studies; Compulsive Behavior; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Female; Humans; Levodopa; Male; Middle Aged; Obsessive Behavior; Parkinson Disease; Risk Factors; Sensitivity and Specificity; Treatment Failure	2019
Dopamine and reward hypersensitivity in Parkinson's disease with impulse control disorder. Brain : a journal of neurology, 2020, 08-01, Volume: 143, Issue:8 Topics: Aged; Antiparkinson Agents; Disruptive, Impulse Control, and Conduct Disorders; Dopamine; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Reward	2020
Impulse control disorder under dopaminergic agonists revealed by acts of violence against animals. Revue neurologique, 2021, Volume: 177, Issue:3 Topics: Animal Welfare; Animals; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Levodopa; Violence	2021
No Change in Prevalence of Impulse Control Disorder Behaviors in Parkinson's Disease During the Last Decade. Movement disorders : official journal of the Movement Disorder Society, 2021, Volume: 36, Issue:2 Topics: Disruptive, Impulse Control, and Conduct Disorders; Humans; Levodopa; Parkinson Disease; Prevalence	2021
Author response to comment on "The association between pain and impulse control behaviours in Parkinson's disease". Parkinsonism & related disorders, 2021, Volume: 83 Topics: Disruptive, Impulse Control, and Conduct Disorders; Humans; Levodopa; Pain; Parkinson Disease	2021
[Stealing as an Impulse Control Disorder Associated with Pramipexole - A Case Report from Forensic Psychiatric Practice]. Psychiatrische Praxis, 2017, Volume: 44, Issue:3 Topics: Antiparkinson Agents; Benzothiazoles; Disruptive, Impulse Control, and Conduct Disorders; Drug Therapy, Combination; Expert Testimony; Female; Humans; Levodopa; Mental Competency; Middle Aged; Parkinson Disease; Pramipexole; Risk Factors; Theft	2017
Measures of impulsivity in Parkinson's disease decrease after DBS in the setting of stable dopamine therapy. Parkinsonism & related disorders, 2017, Volume: 44 Topics: Aged; Antiparkinson Agents; Deep Brain Stimulation; Disruptive, Impulse Control, and Conduct Disorders; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Surveys and Questionnaires	2017
Impulse control disorders in advanced Parkinson's disease with dyskinesia: The ALTHEA study. Movement disorders : official journal of the Movement Disorder Society, 2017, Volume: 32, Issue:11 Topics: Aged; Comorbidity; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agents; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Severity of Illness Index	2017
Sleep and REM sleep behaviour disorder in Parkinson's disease with impulse control disorder. Journal of neurology, neurosurgery, and psychiatry, 2018, Volume: 89, Issue:3 Topics: Aged; Antidepressive Agents; Case-Control Studies; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Polysomnography; REM Sleep Behavior Disorder; Sleep; Video Recording	2018
Improvement of impulse control disorders associated with levodopa-carbidopa intestinal gel treatment in advanced Parkinson's disease. Journal of neurology, 2018, Volume: 265, Issue:6 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Caregivers; Comorbidity; Cost of Illness; Disruptive, Impulse Control, and Conduct Disorders; Drug Combinations; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Gastrostomy; Gels; Humans; Levodopa; Male; Parkinson Disease; Prospective Studies; Psychotropic Drugs; Quality of Life; Severity of Illness Index; Sleep; Treatment Outcome	2018
Impulse control disorders in Parkinson's disease patients with RLS: a cross sectional-study. Sleep medicine, 2018, Volume: 48 Topics: Aged; Case-Control Studies; Cross-Sectional Studies; Disruptive, Impulse Control, and Conduct Disorders; Dopamine; Dopamine Agonists; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Polysomnography; Restless Legs Syndrome	2018
Impulse control disorders in Parkinson's disease: a hard-turning point. Journal of neurology, neurosurgery, and psychiatry, 2019, Volume: 90, Issue:1 Topics: Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Humans; Levodopa; Parkinson Disease	2019
Suggestive association between OPRM1 and impulse control disorders in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2018, Volume: 33, Issue:12 Topics: Adult; Aged; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Female; Gambling; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Receptors, Opioid, mu; Risk Factors	2018
[Devotion to painting in a Parkinson's disease patient]. Rinsho shinkeigaku = Clinical neurology, 2018, Dec-21, Volume: 58, Issue:12 Topics: Aged; Disease Progression; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Humans; Levodopa; Male; Paintings; Parkinson Disease; Substance-Related Disorders	2018
Dopamine dysregulation syndrome induced by proxy. BMJ case reports, 2019, May-16, Volume: 12, Issue:5 Topics: Aged; Carbidopa; Disruptive, Impulse Control, and Conduct Disorders; Drug Combinations; Female; Humans; Levodopa; Parkinson Disease; Substance-Related Disorders; Syndrome	2019
Molecular imaging of impulse control disorders in Parkinson's disease. European journal of nuclear medicine and molecular imaging, 2019, Volume: 46, Issue:11 Topics: Disruptive, Impulse Control, and Conduct Disorders; Dopamine Plasma Membrane Transport Proteins; Humans; Levodopa; Molecular Imaging; Parkinson Disease	2019
Three cases of impulse control disorder in Parkinson's disease patients receiving dopamine replacement therapy. Irish medical journal, 2013, Volume: 106, Issue:1 Topics: Adult; Amantadine; Antiparkinson Agents; Benzothiazoles; Carbidopa; Catechols; Disruptive, Impulse Control, and Conduct Disorders; Drug Combinations; Female; Humans; Indans; Indoles; Levodopa; Male; Middle Aged; Neuroprotective Agents; Parkinson Disease; Pramipexole; Selegiline	2013
Past smoking and current dopamine agonist use show an independent and dose-dependent association with impulse control disorders in Parkinson's disease. Parkinsonism & related disorders, 2013, Volume: 19, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Case-Control Studies; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Dose-Response Relationship, Drug; Female; Humans; Impulsive Behavior; Levodopa; Male; Middle Aged; Parkinson Disease; Severity of Illness Index; Smoking	2013
Decisions under risk in Parkinson's disease: preserved evaluation of probability and magnitude. Neuropsychologia, 2013, Volume: 51, Issue:13 Topics: Aged; Antiparkinson Agents; Case-Control Studies; Decision Making; Disruptive, Impulse Control, and Conduct Disorders; Female; Games, Experimental; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Probability; Psychometrics; Risk-Taking	2013
[Impulsive-compulsive syndrome in Parkinson's disease]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2013, Volume: 113, Issue:7 Pt 2 Topics: Aged; Aged, 80 and over; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agents; Dopamine Agonists; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prevalence; Risk Factors; Russia; Surveys and Questionnaires; Syndrome	2013
Motor phenotypes, medication and mood: further associations with impulsive behaviours in Parkinson's disease. Journal of Parkinson's disease, 2014, Volume: 4, Issue:2 Topics: Affect; Aged; Antiparkinson Agents; Cohort Studies; Disruptive, Impulse Control, and Conduct Disorders; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Phenotype	2014
Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study. Journal of neurology, neurosurgery, and psychiatry, 2014, Volume: 85, Issue:8 Topics: Administration, Cutaneous; Administration, Oral; Age Factors; Aged; Antiparkinson Agents; Benzothiazoles; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole; Sex Factors; Tetrahydronaphthalenes; Thiophenes	2014
A conditioned response as a measure of impulsive-compulsive behaviours in Parkinson's disease. PloS one, 2014, Volume: 9, Issue:2 Topics: Aged; Anxiety; Apathy; Compulsive Behavior; Conditioning, Psychological; Depression; Disruptive, Impulse Control, and Conduct Disorders; Dyskinesias; Humans; Hypokinesia; Impulsive Behavior; Levodopa; Middle Aged; Parkinson Disease; Weights and Measures	2014
Impulse control and repetitive behaviors in Parkinson's disease - are there differences in the relation to dopamine agonist treatment? Journal of the neurological sciences, 2014, Oct-15, Volume: 345, Issue:1-2 Topics: Aged; Antiparkinson Agents; Cross-Sectional Studies; Disruptive, Impulse Control, and Conduct Disorders; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Retrospective Studies	2014
Perceptual decision-making in patients with Parkinson's disease. Journal of psychopharmacology (Oxford, England), 2014, Volume: 28, Issue:12 Topics: Aged; Case-Control Studies; Color Perception Tests; Decision Making; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Reaction Time	2014
Proficient motor impulse control in Parkinson disease patients with impulsive and compulsive behaviors. Pharmacology, biochemistry, and behavior, 2015, Volume: 129 Topics: Antiparkinson Agents; Case-Control Studies; Disruptive, Impulse Control, and Conduct Disorders; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Reaction Time	2015
Behavioral effects of levodopa. Movement disorders : official journal of the Movement Disorder Society, 2015, Volume: 30, Issue:1 Topics: Animals; Antiparkinson Agents; Behavioral Symptoms; Deep Brain Stimulation; Disruptive, Impulse Control, and Conduct Disorders; Humans; Levodopa; Parkinson Disease	2015
Association between REM sleep behaviour disorder and impulse control disorder in patients with Parkinson's disease. Neurologia (Barcelona, Spain), 2017, Volume: 32, Issue:8 Topics: Administration, Oral; Aged; Brief Psychiatric Rating Scale; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Female; Humans; Levodopa; Male; Parkinson Disease; Prevalence; REM Sleep Behavior Disorder	2017
Dopamine D3 receptor Ser9Gly variant is associated with impulse control disorders in Parkinson's disease patients. Parkinsonism & related disorders, 2016, Volume: 30 Topics: Adult; Aged; Asian People; Case-Control Studies; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Female; Genetic Predisposition to Disease; Genotype; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Polymorphism, Single Nucleotide; Prospective Studies; Receptors, Dopamine D3	2016
Dopamine and impulse control disorders in Parkinson's disease. Annals of neurology, 2008, Volume: 64 Suppl 2 Topics: Brain; Disruptive, Impulse Control, and Conduct Disorders; Dopamine; Dopamine Agonists; Humans; Levodopa; Male; Parkinson Disease; Risk Factors	2008
Preliminary evaluation of the DDS-PC inventory: a new tool to assess impulsive-compulsive behaviours associated to dopamine replacement therapy in Parkinson's disease. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2009, Volume: 30, Issue:4 Topics: Aged; Antiparkinson Agents; Caregivers; Compulsive Personality Disorder; Disruptive, Impulse Control, and Conduct Disorders; Dopamine; Dopamine Agents; Female; Gambling; Humans; Levodopa; Longitudinal Studies; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Personality Tests; Psychometrics; Reward; ROC Curve; Surveys and Questionnaires	2009
Impulse control disorders in Parkinson's disease in a Chinese population. Neuroscience letters, 2009, Nov-06, Volume: 465, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Alcohol Drinking; Antiparkinson Agents; China; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Dose-Response Relationship, Drug; Female; Humans; Interviews as Topic; Levodopa; Male; Middle Aged; Parkinson Disease; Surveys and Questionnaires	2009
Long term follow-up of Parkinson's disease patients with impulse control disorders. Parkinsonism & related disorders, 2010, Volume: 16, Issue:5 Topics: Adult; Age Factors; Aged; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Female; Humans; Levodopa; Longitudinal Studies; Male; Middle Aged; Parkinson Disease; Psychiatric Status Rating Scales; Retrospective Studies; Time Factors	2010
Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Archives of neurology, 2010, Volume: 67, Issue:5 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Binge-Eating Disorder; Comorbidity; Cross-Sectional Studies; Disruptive, Impulse Control, and Conduct Disorders; Female; Gambling; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole; Prevalence; Risk Factors; Sexual Dysfunctions, Psychological	2010
Pathological gambling in PD: did the devil make me do it? Neurology, 2010, Nov-09, Volume: 75, Issue:19 Topics: Disruptive, Impulse Control, and Conduct Disorders; Gambling; Humans; Levodopa; Parkinson Disease	2010
Involvement of the subthalamic nucleus in impulse control disorders associated with Parkinson's disease. Brain : a journal of neurology, 2011, Volume: 134, Issue:Pt 1 Topics: Adult; Aged; Analysis of Variance; Antiparkinson Agents; Brain Waves; Deep Brain Stimulation; Disruptive, Impulse Control, and Conduct Disorders; Dyskinesia, Drug-Induced; Electrodes, Implanted; Electrophysiology; Female; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Parkinson Disease; Subthalamic Nucleus	2011
Is pathological gambling in Parkinson's disease reduced by amantadine? Annals of neurology, 2011, Volume: 69, Issue:1 Topics: Aged; Amantadine; Antiparkinson Agents; Disruptive, Impulse Control, and Conduct Disorders; Female; Gambling; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Randomized Controlled Trials as Topic; Treatment Outcome	2011
Valproate for the treatment of medication-induced impulse-control disorders in three patients with Parkinson's disease. Parkinsonism & related disorders, 2011, Volume: 17, Issue:5 Topics: Adult; Anticonvulsants; Antiparkinson Agents; Disruptive, Impulse Control, and Conduct Disorders; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Valproic Acid	2011
Dopamine agonists vs levodopa in impulse control disorders. Archives of neurology, 2011, Volume: 68, Issue:4 Topics: Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Humans; Levodopa	2011
Impulse control disorders in Chinese Parkinson's disease patients: the effect of ergot derived dopamine agonist. Parkinsonism & related disorders, 2011, Volume: 17, Issue:8 Topics: Aged; Antiparkinson Agents; Asian People; Bromocriptine; China; Cross-Sectional Studies; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Drug Therapy, Combination; Ergot Alkaloids; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prospective Studies	2011
[Impulse control disorders in Parkinson's disease: A cohort of 35 patients]. Revue neurologique, 2012, Volume: 168, Issue:2 Topics: Adult; Age of Onset; Aged; Antiparkinson Agents; Case-Control Studies; Cohort Studies; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Dose-Response Relationship, Drug; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Retrospective Studies; Socioeconomic Factors; Withholding Treatment	2012
Comparison of personality characteristics in Parkinson disease patients with and without impulse control disorders and in healthy volunteers. Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology, 2012, Volume: 25, Issue:1 Topics: Aged; Case-Control Studies; Disruptive, Impulse Control, and Conduct Disorders; Female; Humans; Levodopa; Male; Middle Aged; MMPI; Parkinson Disease; Time Factors	2012
Subthalamic stimulation in Parkinson's disease: restoring the balance of motivated behaviours. Brain : a journal of neurology, 2012, Volume: 135, Issue:Pt 5 Topics: Aged; Antiparkinson Agents; Cohort Studies; Deep Brain Stimulation; Disruptive, Impulse Control, and Conduct Disorders; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Motivation; Neuropsychological Tests; Parkinson Disease; Psychiatric Status Rating Scales; Severity of Illness Index; Statistics, Nonparametric; Subthalamic Nucleus	2012
Effects of dopamine agonist dose and gender on the prognosis of impulse control disorders in Parkinson's disease. Parkinsonism & related disorders, 2012, Volume: 18, Issue:10 Topics: Aged; Amantadine; Antidepressive Agents; Antiparkinson Agents; Data Collection; Depression; Disease Progression; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Dose-Response Relationship, Drug; Female; Humans; Levodopa; Male; Middle Aged; Monoamine Oxidase Inhibitors; Parkinson Disease; Predictive Value of Tests; Prevalence; Prognosis; Prospective Studies; Risk Factors; Self Report; Sex Distribution; Surveys and Questionnaires	2012
Duration of L-dopa and dopamine agonist monotherapy in Parkinson's disease. Scottish medical journal, 2012, Volume: 57, Issue:4 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Confidence Intervals; Disorders of Excessive Somnolence; Disruptive, Impulse Control, and Conduct Disorders; Dizziness; Dopamine Agonists; Drug Therapy, Combination; Female; Hallucinations; Humans; Indoles; Kaplan-Meier Estimate; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole; Time Factors	2012
Valproate as a treatment for dopamine dysregulation syndrome (DDS) in Parkinson's disease. Journal of neurology, 2013, Volume: 260, Issue:2 Topics: Aged; Aged, 80 and over; Akathisia, Drug-Induced; Anticonvulsants; Carbidopa; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agents; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Valproic Acid	2013
Pathological gambling in two patients on dopamine replacement therapy for Parkinson's disease. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2004, Volume: 25, Issue:2 Topics: Antiparkinson Agents; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agents; Dose-Response Relationship, Drug; Gambling; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Self Medication	2004
Impulse control disorders and dopaminergic drugs. Archives of neurology, 2006, Volume: 63, Issue:2 Topics: Antiparkinson Agents; Disruptive, Impulse Control, and Conduct Disorders; Humans; Levodopa; Parkinson Disease	2006
Medical hazards of the internet: gambling in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2006, Volume: 21, Issue:10 Topics: Adult; Antiparkinson Agents; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Drug Therapy, Combination; Gambling; Humans; Internet; Levodopa; Male; Parkinson Disease; Pergolide	2006
Dopamine agonist-induced pathological gambling in restless legs syndrome due to multiple sclerosis. Movement disorders : official journal of the Movement Disorder Society, 2007, Mar-15, Volume: 22, Issue:4 Topics: Adult; Benserazide; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Drug Therapy, Combination; Female; Gambling; Humans; Levodopa; Multiple Sclerosis; Restless Legs Syndrome	2007
Treatment of juvenile Parkinson disease and the recurrent emergence of pathologic gambling. Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology, 2007, Volume: 20, Issue:1 Topics: Adolescent; Adult; Antiparkinson Agents; Benzothiazoles; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Female; Gambling; Humans; Levodopa; Parkinsonian Disorders; Pergolide; Pramipexole; Recurrence	2007
Pathologic gambling in Parkinson's disease: a behavioral manifestation of pharmacologic treatment? Movement disorders : official journal of the Movement Disorder Society, 2000, Volume: 15, Issue:5 Topics: Adult; Aged; Antiparkinson Agents; Disruptive, Impulse Control, and Conduct Disorders; Female; Gambling; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	2000
Drugs can trigger pathological gambling. Prescrire international, 2002, Volume: 11, Issue:57 Topics: Antiparkinson Agents; Disruptive, Impulse Control, and Conduct Disorders; Gambling; Humans; Levodopa; Parkinson Disease	2002